Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AXLX in play
AXLX in PLAY - Small Flt Rumor of an update P/R soon..
DIGX starting a move micro flt
thanks for the pump, sold all in the .0055 range
BVTK in play was .10Plus a few months ago. Tax loss selling over .0006
BVTK in play was .10+ afew months ago - Tax loss selling over...
who wants to lay odds the float has drastically increased in the past few days?
Is this a death Spiral, r they bloating the float
some ones manipulating down who sells 30k doesn't even cover the cost of the trade.
I dumped yesterday - stories good death spiral killing this stock
Keep an Eye on DIGX small flt rumor of news
DRMC in Play .0007
it looks like they have another 150K to dump before the bounce, just an estimate
NBDR great news today! Good price action! Micro flt!
ZAAP major news just released
ZAAP news just out!!!!
DIGX place on news watch - small fl .0004
ALERT DIGX .0005 micro flt moving
DIGX .0004 micro flt News forthcoming
US STEM CELL (Bioheart) Announces Insiders Intend to Purchase Company Common Stock in the Open Market
SUNRISE, FL / ACCESSWIRE / September 17, 2015 / US STEM CELL, Inc. (in transition from Bioheart, Inc. (OTCQB: BHRT)) announces today that "insiders" led by Dr. William P. Murphy, Jr., Chairman and Mike Tomas, President and CEO, intend to purchase, in the open market, up to 5% of the issued and outstanding Common Stock of the Company. The planned insider purchases are subject to customary restrictions based upon any of the participant's knowledge of material non-public information and are further subject to federal securities disclosure rules. As the planned insider purchases are to be executed by individuals, US STEM CELL cannot guarantee the number of shares to be purchased or the time frame in which these shares will be bought in the open market.
US STEM CELL also reports that as part of its January 13, 2015 meeting, the Board of Directors approved a corporate stock repurchase plan; subsequently, the Company has purchased 23.8 million Common Stock shares. The purchases were made in the open market and are accounted for as Treasury Stock. Independent of the above insider stock purchase plan, the Company may, from time to time, continue with its own stock purchases.
"Our confidence is high," stated Dr. Murphy, Chairman of US STEM CELL, Inc. "Market activity surrounding our publicly traded Common Stock has provided an attractive opportunity for insiders, as it does for all investors, to benefit from our strategic efforts to build US STEM CELL into a world class company. We believe the opportunity for extraordinary investment gains exists and we plan, within the regulatory guidelines, to actively seize upon the opportunity to increase our ownership stakes in the Company."
About U.S. Stem Cell, Inc.
US Stem cell, Inc. (formerly Bioheart, Inc.) is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. We believe that regenerative medicine / cellular therapeutics will play a large role in positively changing the natural history of diseases ultimately, we contend, lessening patient burdens as well as reducing the associated economic impact disease imposes upon modern society.
Our business, which includes three operating divisions (US Stem Cell Training, Vetbiologics and US Stem Cell Clinic) includes the development of proprietary cell therapy products as well as revenue generating physician and patient based regenerative medicine / cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. Management maintains that revenues and their associated cash in-flows generated from our businesses will, over time, provide funds to support our clinical development activities as they do today for our general business operations. We believe the combination of our own therapeutics pipeline combined with our revenue generating capabilities provides the Company with a unique opportunity for growth and a pathway to profitability.
Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate", or "continue", or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2014, and its Quarterly Reports on Form 10-Q.
Media Contact: US STEM CELL, Inc.
13794 NW 4th Street, Suite 212
Sunrise, Florida 33325
Phone: 954.835.1500
bioheart@bioheartinc.com
SOURCE: US STEM CELL, Inc.
ARCS in play
ARCS in play HOD small flt
DIGX micro flt starting to move
The Litchfield Fund Announces Investment in Harvest SoulMarketwired(Wed, Jul 1)
Harvest Soul Organic Juices Expanding to West CoastMarketwired(Mon, Jun 22)
FRESH PROMISE FOODS, INC. FinancialsEDGAR Online Financials(Thu, May 28)
10-Q for Fresh Promise Foods, Inc.Company Spotlight(Sun, May 24)
FRESH PROMISE FOODS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 22)
Harvest Soul Organic Chewable Juices Receives Third Purchase Order From UNFI in Support of Whole Foods Market GrowthMarketwired(Fri, May 1)
10-K for Fresh Promise Foods, Inc.Company Spotlight(Wed, Apr 29)
Harvest Soul Organic Chewable Juices to Participate in Alive! Expo, Atlanta, May 2-3, 2015Marketwired(Tue, Apr 28)
FRESH PROMISE FOODS, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 27)
Harvest Soul Organic Chewable Juices Earns Non-GMO Project VerificationMarketwired(Mon, Apr 27)
Harvest Soul Organic Juices Shaking Up the Organic Juice Category at Whole Foods MarketsMarketwired(Wed, Apr 15)
Harvest Soul Organic Juices Shake Up Natural Products Expo West Show With Chewable JuicesMarketwired(Tue, Mar 24)
Harvest Soul Organic Chewable Juices Schedules First Demos in Whole Foods MarketsMarketwired(Wed, Mar 4)
MULTIMEDIA UPDATE - Harvest Soul Organic Chewable Juices to Be Sold in Whole Foods MarketsMarketwired(Wed, Feb 4)
Harvest Soul Organic Chewable Juices to Be Sold in Whole Foods MarketsMarketwired(Tue, Feb 3)
At this point save your money.. @ .0003 great buy now its questionable... whoever did a great job on this p@d
The company scooping up these cheap share 1.5mil buyback announced
Fish - lol
ILIM .0001 little birdie said load up...
Heard on another board someone received a email from the company that updates were forthcoming.. Can anyone confirm? Would like to add but want to make sure...
CTIX HUGE NEWS FDA
PTOP in play huge news just out
PTOP in play HUGE NEWS just out moments ago
Those were set up p/r's - I bet the next one ignites this rocket...
IMHO
Hopefully john will release news after the 10q he was talking about..
FPFI News Just hit^^^^
JUST HIT FPFI NEWS!! MOVING UP!
Last update: 01/07/2015 11:34:49 am
Associated Press
WILLIAMS, Ore.--Forty-two years after Oregon became the first state to decriminalize small amounts of marijuana, the state is taking its first steps along a road leading to state-licensed stores selling limited amounts of it to anyone over 21.
"Oregon has long been a pioneer on sensible marijuana policies," said Anthony Johnson, chief petitioner on Measure 91, which on Wednesday makes Oregon the fourth state to adopt laws legalizing recreational use of cannabis for people old enough to drink.
He added though that he doesn't expect much increased demand for it.
Smoking it in public is illegal, but in Portland police are discouraging residents from calling 911 to report smokers.
The Portland chapter of National Organization for the Reform of Marijuana Laws posted on its website that it would have a tent set up on the west side of the Burnside Bridge for a midnight countdown to the end of marijuana prohibition.
Adults will be allowed to possess up to half a pound and grow four plants, but not to buy or sell it yet. It will be a few months to more than a year before it is legal to sell, and then only with a state permit.
The Legislature is considering a bill to allow medical marijuana dispensaries to start selling small amounts to anyone over 21 on Oct. 1, in order to get over the incongruity of marijuana being legal to have and to grow, but not to buy.
The state-regulated retail system is not expected to be fully up and running until late next year. Growers are expected to be able to start applying for licenses in January, with permits for processers, wholesalers and retailers rolling out in succession.
(c) 2015 The Associated Press
(END) Dow Jones Newswires
July 01, 2015 11:34 ET (15:34 GMT)
Last update: 01/07/2015 11:34:49 am
Associated Press
WILLIAMS, Ore.--Forty-two years after Oregon became the first state to decriminalize small amounts of marijuana, the state is taking its first steps along a road leading to state-licensed stores selling limited amounts of it to anyone over 21.
"Oregon has long been a pioneer on sensible marijuana policies," said Anthony Johnson, chief petitioner on Measure 91, which on Wednesday makes Oregon the fourth state to adopt laws legalizing recreational use of cannabis for people old enough to drink.
He added though that he doesn't expect much increased demand for it.
Smoking it in public is illegal, but in Portland police are discouraging residents from calling 911 to report smokers.
The Portland chapter of National Organization for the Reform of Marijuana Laws posted on its website that it would have a tent set up on the west side of the Burnside Bridge for a midnight countdown to the end of marijuana prohibition.
Adults will be allowed to possess up to half a pound and grow four plants, but not to buy or sell it yet. It will be a few months to more than a year before it is legal to sell, and then only with a state permit.
The Legislature is considering a bill to allow medical marijuana dispensaries to start selling small amounts to anyone over 21 on Oct. 1, in order to get over the incongruity of marijuana being legal to have and to grow, but not to buy.
The state-regulated retail system is not expected to be fully up and running until late next year. Growers are expected to be able to start applying for licenses in January, with permits for processers, wholesalers and retailers rolling out in succession.
(c) 2015 The Associated Press
(END) Dow Jones Newswires
July 01, 2015 11:34 ET (15:34 GMT)